Caliber Wealth Management (Utah)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,299
Closed -$475K 77
2022
Q4
$475K Buy
+1,299
New +$461K 0.36% 57

Other funds holding LLY

Caliber Wealth Management (Utah)'s LLY Position: Q1 2023 in Review

Caliber Wealth Management (Utah) sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 1,299 shares — an estimated $475K sold.

Caliber Wealth Management (Utah) first reported a position in LLY in Q4 2022 and held it in 1 quarter. The position peaked at $475K in Q4 2022. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

  • Caliber Wealth Management (Utah) reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
  • Caliber Wealth Management (Utah) sold 1,299 Eli Lilly shares in Q1 2023, an estimated $475K.
  • Caliber Wealth Management (Utah) first reported a position in Eli Lilly in Q4 2022 and held it in 1 quarter.
  • Caliber Wealth Management (Utah)'s Eli Lilly position peaked at $475K in Q4 2022.
  • 2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Caliber Wealth Management (Utah)'s 13F filing for Q1 2023, filed 10 Apr 2023.